These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 38031814
1. In utero/peripartum antiretroviral therapy exposure and mental health outcomes at 8-18 years old: A longitudinal comparative study of children with perinatally acquired HIV, children perinatally HIV exposed but uninfected, and children unexposed uninfected from Uganda. Coventry A, Sikorskii A, Zalwango SK, Familiar-Lopez I, Cardino VN, Giordani B, Ezeamama AE. Res Nurs Health; 2024 Apr; 47(2):195-207. PubMed ID: 38031814 [Abstract] [Full Text] [Related]
2. Growth differences by school-age and adolescence according to in utero and peripartum antiretroviral therapy exposure among Ugandan children. Awadu JE, Zalwango SK, Sikorskii A, Giordani B, Bovin MJ, Musoke PM, Ezeamama AE. Medicine (Baltimore); 2023 Jan 27; 102(4):e32677. PubMed ID: 36705393 [Abstract] [Full Text] [Related]
4. In utero and peripartum antiretroviral exposure as predictor of cognition in 6- to 10-year-old HIV-exposed Ugandan children - a prospective cohort study. Ezeamama AE, Zalwango SK, Sikorskii A, Tuke R, Musoke PM, Giordani B, Boivin MJ. HIV Med; 2021 Aug 27; 22(7):592-604. PubMed ID: 33860626 [Abstract] [Full Text] [Related]
5. Lower Insulin Sensitivity Through 36 Months of Life With in Utero HIV and Antiretroviral Exposure in Botswana: Results From the Tshilo Dikotla Study. Jao J, Bonner LB, Dobinda K, Powis KM, Sun S, Legbedze J, Mmasa KN, Makhema J, Mmalane M, Kgole S, Masasa G, Moyo S, Gerschenson M, Mohammed T, Abrams EJ, Kurland IJ, Geffner ME. Clin Infect Dis; 2024 Sep 26; 79(3):727-733. PubMed ID: 38531012 [Abstract] [Full Text] [Related]
6. Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero. Ajaykumar A, Zhu M, Kakkar F, Brophy J, Bitnun A, Alimenti A, Soudeyns H, Saberi S, Albert AYK, Money DM, Côté HCF, CIHR Team in Cellular Aging and HIV Comorbidities in Women and Children (Children and Women: AntiRetrovirals and Markers of Aging [CARMA]). J Infect Dis; 2021 Feb 24; 223(4):621-631. PubMed ID: 32638023 [Abstract] [Full Text] [Related]
9. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study. Boivin MJ, Maliwichi-Senganimalunje L, Ogwang LW, Kawalazira R, Sikorskii A, Familiar-Lopez I, Kuteesa A, Nyakato M, Mutebe A, Namukooli JL, Mallewa M, Ruiseñor-Escudero H, Aizire J, Taha TE, Fowler MG. Lancet HIV; 2019 Aug 24; 6(8):e518-e530. PubMed ID: 31122797 [Abstract] [Full Text] [Related]
10. Altered White Matter Tracts in the Somatosensory, Salience, Motor, and Default Mode Networks in 7-Year-Old Children Living with Human Immunodeficiency Virus: A Tractographic Analysis. Madzime J, Holmes M, Cotton MF, Laughton B, van der Kouwe AJW, Meintjes EM, Jankiewicz M. Brain Connect; 2022 May 24; 12(4):302-319. PubMed ID: 34107770 [Abstract] [Full Text] [Related]
13. Vitamin D and Probability of Developmental Disorders among Perinatally HIV-Affected and Unaffected Ugandan Children. Awadu JE, Giordani B, Sikorskii A, Abbo C, Fenton JI, Zalwango S, Ezeamama AE. Nutrients; 2023 Apr 22; 15(9):. PubMed ID: 37432158 [Abstract] [Full Text] [Related]
14. Neurocognitive outcomes of children exposed to and living with HIV aged 3-5 years in Kilifi, Kenya. Chongwo EJ, Wedderburn CJ, Nyongesa MK, Sigilai A, Mwangi P, Thoya J, Odhiambo R, Ngombo K, Kabunda B, Newton CR, Abubakar A. Front Reprod Health; 2023 Apr 22; 5():1193183. PubMed ID: 37732169 [Abstract] [Full Text] [Related]
15. 18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission. Leroy V, Ekouevi DK, Becquet R, Viho I, Dequae-Merchadou L, Tonwe-Gold B, Rouet F, Sakarovitch C, Horo A, Timité-Konan M, Rouzioux C, Dabis F, ANRS 1201/1202 DITRAME PLUS Study Group. PLoS One; 2008 Feb 20; 3(2):e1645. PubMed ID: 18286200 [Abstract] [Full Text] [Related]
16. Longer prior exposure to zidovudine/lamivudine-containing combination antiretroviral therapy, age, and male gender are each associated with reduced subcutaneous adipose tissue. Vrouenraets SM, Wit FW, Garcia EF, Huber M, Brinkman K, Moyle G, Domingo P, Tarr PE, Podzamczer D, Ristola M, Gatell JM, Livrozet JM, Furrer H, Reiss P, PREPARE Study Group. HIV Clin Trials; 2012 Feb 20; 13(2):103-10. PubMed ID: 22510357 [Abstract] [Full Text] [Related]
17. Language outcomes of preschool children who are HIV-exposed uninfected: An analysis of a South African cohort. Green F, du Plooy C, Rehman AM, Nhapi RT, Lake MT, Barnett W, Hoffman N, Zar HJ, Donald KA, Stein DJ, Wedderburn CJ. PLoS One; 2024 Feb 20; 19(4):e0297471. PubMed ID: 38598467 [Abstract] [Full Text] [Related]
18. In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children. Yao TJ, Malee K, Zhang J, Smith R, Redmond S, Rice ML, Frederick T, Torre P, Mellins CA, Hoffman HJ, Williams PL. AIDS Patient Care STDS; 2023 Mar 20; 37(3):119-130. PubMed ID: 36827595 [Abstract] [Full Text] [Related]
19. Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda. Towler WI, Barlow-Mosha L, Church JD, Bagenda D, Ajuna P, Mubiru M, Musoke P, Eshleman SH. AIDS Res Hum Retroviruses; 2010 May 20; 26(5):563-8. PubMed ID: 20455758 [Abstract] [Full Text] [Related]
20. Impact of antenatal antiretroviral drug exposure on the growth of children who are HIV-exposed uninfected: the national South African Prevention of Mother to Child Evaluation cohort study. Ramokolo V, Kuhn L, Lombard C, Jackson D, Goga AE. BMC Infect Dis; 2022 Dec 06; 22(1):908. PubMed ID: 36474212 [Abstract] [Full Text] [Related] Page: [Next] [New Search]